A phase II trial of Cyclosporin A in Early Adverse Risk CLL
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2019
Price : $35 *
At a glance
- Drugs Ciclosporin (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Pharmacodynamics
- Acronyms CyCLLe
- 31 Aug 2018 Biomarkers information updated
- 06 Jul 2017 Status changed from recruiting to completed.
- 29 Mar 2016 Accrual to date is 50% according to United Kingdom Clinical Research Network record.